Which statement about CA125 testing is accurate?

Prepare for the CMID Test. Study with flashcards and multiple choice questions, each question contains hints and explanations. Get ready for your exam with confidence!

Multiple Choice

Which statement about CA125 testing is accurate?

Explanation:
CA125 is a marker most often used to help manage ovarian cancer, but it is not specific to ovarian cancer. Levels can be elevated in many non-movarian conditions, such as endometriosis, pelvic inflammatory disease, liver or kidney disease, and even during menstruation or pregnancy. Because of these noncancer-related elevations, a high CA125 does not definitively indicate ovarian cancer, and a normal CA125 does not completely exclude it—especially in early-stage disease or certain tumor subtypes. This limited specificity is why CA125 is not used as a general screening test for ovarian cancer in the population, and it’s not a universal cancer marker. It remains most useful as part of a broader diagnostic workup and for monitoring treatment response or recurrence after therapy.

CA125 is a marker most often used to help manage ovarian cancer, but it is not specific to ovarian cancer. Levels can be elevated in many non-movarian conditions, such as endometriosis, pelvic inflammatory disease, liver or kidney disease, and even during menstruation or pregnancy. Because of these noncancer-related elevations, a high CA125 does not definitively indicate ovarian cancer, and a normal CA125 does not completely exclude it—especially in early-stage disease or certain tumor subtypes. This limited specificity is why CA125 is not used as a general screening test for ovarian cancer in the population, and it’s not a universal cancer marker. It remains most useful as part of a broader diagnostic workup and for monitoring treatment response or recurrence after therapy.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy